Health
Moderna, Merck mRNA cancer vaccine prevents melanoma from returning
Headline as filed by The Hill. PageNews does not write or rewrite headlines.
PageNews Brief
One publisher, The Hill, has reported this so far, at 14:54 UTC on 19 August 2026.
No other outlet PageNews follows has covered it. If one files, their report will be added to this page and the comparison below will fill out.
The coverage is filed under Health. The publisher's own headline, summary and link is below.
Compiled by PageNews from the report listed below — who filed it and when. No publisher wrote this section.
Coverage from 1 publisher
-
The Hill
Moderna, Merck mRNA cancer vaccine prevents melanoma from returning
An experimental personalized mRNA-based cancer vaccine from Merck and Moderna was successful at preventing melanoma from returning or spreading in a late-stage trial of high risk patients, the compani
Read on The Hill →
Reader comments
Comments are written by readers. PageNews does not check them and does not stand behind them, and a name here is a name someone typed, not a person we have identified.
Nobody has commented on this story yet.